A detailed history of Wealth Collab, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wealth Collab, LLC holds 753 shares of NVO stock, worth $67,182. This represents 0.04% of its overall portfolio holdings.

Number of Shares
753
Previous 860 12.44%
Holding current value
$67,182
Previous $102 Million 36.75%
% of portfolio
0.04%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$85.0 - $120.04 $9,095 - $12,844
-107 Reduced 12.44%
753 $64.8 Million
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $612 - $815
6 Added 0.7%
860 $110 Million
Q4 2023

Apr 03, 2024

BUY
$87.78 - $105.45 $74,964 - $90,054
854 New
854 $88.3 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $201B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wealth Collab, LLC Portfolio

Follow Wealth Collab, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Collab, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Collab, LLC with notifications on news.